Skip to main content

Your search for “Pancreatic Cancer” returned 85 results

Study Uses Precision Medicine to Speed Drug Testing for Pancreatic Cancer

April 15, 2021

Moores Cancer Center at UC San Diego Health is among the few clinical trial sites in the U.S. for the Pancreatic Cancer Action Network’s (PanCAN) newly created Precision Promise, the first large-scale precision medicine trial designed to transform outcomes for patients with pancreatic cancer.

Patients with Gastrointestinal Tumors at Higher Risk of Other Cancers

May 1, 2015

…temporal relationship between gastrointestinal stromal tumors (GIST) and other cancers. The results, published by Cancer on April 30, indicate that one in 5.8 patients with GIST will develop additional malignancies before and after their diagnosis.

New Screening Tool IDs 95 Percent of Stage 1 Pancreatic Cancer

March 21, 2022

UC San Diego study finds new screening tool flags 95 percent of stage 1 pancreatic cancers.

Researchers Develop New Strategy to Target KRAS Mutant Cancer

September 13, 2017

In a new study, published this month in Cancer Discovery, University of California San Diego School of Medicine researchers report that approximately half of lung and pancreatic cancers that originate with a KRAS mutation become addicted to the gene as they progress.

UC San Diego Cancer Biologist Receives Claugus Award for Medical Research

October 11, 2023

University of California San Diego cancer biologist Tatiana Hurtado de Mendoza has been named the recipient of the 2023 Claugus Award for Medical Research. The award was established in 2021 by the Foundation For A Better World.

New Blood Test Rapidly Detects Signs of Pancreatic Cancer

May 17, 2018

…test to screen for pancreatic cancer in a drop of blood. New Blood Test Rapidly Detects Signs of Pancreatic Cancer Pancreatic cancer is expected to become the second deadliest cancer in the United States by 2030. It is tough to cure because it is usually not discovered until it has…

UC San Diego Health Researchers Help Launch Second Pancreas Cancer “Dream Team”

October 26, 2017

…and physicians at Moores Cancer Center at UC San Diego Health, in partnership with colleagues at MD Anderson Cancer Center in Texas, Johns Hopkins University in Maryland and elsewhere, have been awarded a $7 million grant over four years by Stand Up to Cancer (SU2C) to create a “dream team”…

Stand Up To Cancer Grant Funds UC San Diego Health Research in Pancreatic Cancer

November 20, 2018

A team of University of California San Diego School of Medicine researchers have been awarded a $1 million Stand Up To Cancer (SU2C) grant to test drugs that block signals that play a critical role in driving growth and progression of pancreatic cancer.

Prevention and Screening Clinic at UC San Diego Health Helping to Reduce Pancreatic Cancer

November 29, 2018

Moores Cancer Center at UC San Diego Health launched the Pancreatic Cancer Prevention and Screening Clinic in an attempt to reduce the number of people who develop the disease and improve survival for those who do. Every day in the U.S., 145 people are diagnosed and every 12 minutes someone…

Early Biomarker for Pancreatic Cancer Identified

May 15, 2012

Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have identified a new biomarker and therapeutic target for pancreatic cancer, an often-fatal disease for which there is currently no reliable method for early detection or therapeutic intervention.

Category navigation with Social links